as 12-18-2024 10:36am EST
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
Founded: | 1954 | Country: | United States |
Employees: | N/A | City: | GREENFIELD |
Market Cap: | 6.3B | IPO Year: | 2018 |
Target Price: | $16.75 | AVG Volume (30 days): | 4.5M |
Analyst Decision: | Buy | Number of Analysts: | 8 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.41 | EPS Growth: | N/A |
52 Week Low/High: | $11.40 - $18.80 | Next Earning Date: | 11-07-2024 |
Revenue: | $4,454,000,000 | Revenue Growth: | 1.99% |
Revenue Growth (this year): | 2.24% | Revenue Growth (next year): | 2.88% |
ELAN Breaking Stock News: Dive into ELAN Ticker-Specific Updates for Smart Investing
MT Newswires
9 days ago
Insider Monkey
17 days ago
Insider Monkey
22 days ago
Morningstar Research
23 days ago
PR Newswire
23 days ago
Argus Research
a month ago
Argus Research
a month ago
MT Newswires
a month ago
The information presented on this page, "ELAN Elanco Animal Health Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.